(EMAILWIRE.COM, December 21, 2018 ) According to a new market research report "Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 5.97 Billion by 2023 from an estimated USD 3.43 Billion in 2018, at a CAGR of 11.7%.

The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the Healthcare Analytical Testing Services.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=108923833

On the basis of type, the bioanalytical testing segment accounted for the largest share of the global Healthcare Analytical Testing Services Market. The large share of this segment is due to increasing number of drugs in the biopharmaceutical pipeline and the growing biopharmaceutical industry.

Based on end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the Healthcare Analytical Testing Services Market. The large share of this segment can be attributed to increasing outsourcing of analytical testing services by pharmaceutical and biopharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time required to validate the process and product.

Ask For Discount on Report:
https://www.marketsandmarkets.com/discountreports.asp?id=108923833

North America accounted for the largest share of the Healthcare Analytical Testing Services Market in 2017, followed by Europe and Asia Pacific.

The prominent players in the global Healthcare Analytical Testing Services Market are Eurofins Scientific (Luxembourg), Wuxi PharmaTech (China), and Charles River Laboratories (US) held the major share of the Healthcare Analytical Testing Services Market and will continue to dominate the market between 2018 and 2023.

Get Free 10% Customization on Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=108923833